{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:51:21Z","timestamp":1761659481796,"version":"build-2065373602"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11873-8","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:46:34Z","timestamp":1761659194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time to recovery among tuberculosis patients receiving\u00a0anti-Koch\u2019s drug in Ibadan, Oyo State, Nigeria"],"prefix":"10.1186","volume":"25","author":[{"given":"Yusuff Akinkunmi","family":"Olasunkanmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotimi Felix","family":"Afolabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olowolafe Tubosun","family":"Alex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayo S.","family":"Adebowale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeniyi Francis","family":"Fagbamigbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"11873_CR1","unstructured":"World Health Organization(2017).Global tuberculosis report 2017.World Health Organization.https:\/\/iris.who.int\/handle\/10665\/259366. License: CC BY-NC-SA 3.0 IGO"},{"key":"11873_CR2","unstructured":"WHO (2018) Global Tuberculosis Report.https:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"11873_CR3","doi-asserted-by":"crossref","unstructured":"Erah, P. O., & Ojieabu, W. (2009). Success of the control of tuberculosis in Nigeria: A review. International Journal of Health Research, 2(1), 3-14. https:\/\/doi.org\/10.4314\/ijhr.v2i1.55382","DOI":"10.4314\/ijhr.v2i1.55382"},{"key":"11873_CR4","unstructured":"World Health Organization. Global tuberculosis control: WHO report 2010. Geneva: World Health Organization; 2010. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/44425"},{"key":"11873_CR5","unstructured":"World Health Organization. Global tuberculosis report 2016. Geneva: World Health Organization; 2016. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/250441"},{"key":"11873_CR6","unstructured":"Kanabus A. TB in Nigeria \u2013 Funding, children, diagnosing TB, HIV\/TB. GHE: Information about Tuberculosis. 2020;(1146692):1146692."},{"issue":"1","key":"11873_CR7","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1186\/s41182-018-0114-9","volume":"46","author":"FA Ogbo","year":"2018","unstructured":"Ogbo FA, Ogeleka P, Okoro A, Olusanya BO, Olusanya J, Ifegwu IK, et al. Tuberculosis disease burden and attributable risk factors in Nigeria, 1990\u20132016. Trop Med Health. 2018;46(1):30. doi:10.1186\/s41182-018-0100-0","journal-title":"Trop Med Health"},{"key":"11873_CR8","unstructured":"World Health Organization (WHO). Global tuberculosis report 2019. Geneva: World Health Organization; 2019."},{"issue":"71","key":"11873_CR9","first-page":"40110","volume":"55","author":"G Belete","year":"2020","unstructured":"Belete G, Gobena A, Girmay M, SB. Treatment outcome of tuberculosis patients under directly observed treatment in addis Ababa. Brazilian J Infect Dis. 2020;55(71):40110.","journal-title":"Brazilian J Infect Dis"},{"key":"11873_CR10","doi-asserted-by":"crossref","unstructured":"Chaves-Torres NM, Fadul S, Accinelli RA. Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis. PLoS ONE. 2019;14(12):e0226507. doi:10.1371\/journal.pone.0226507","DOI":"10.1371\/journal.pone.0226507"},{"key":"11873_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/486507","volume":"2013","author":"K Bouti","year":"2013","unstructured":"Bouti K, Aharmim M, Marc K, Soualhi M, Zahraoui R, Benamor J, et al. Factors influencing sputum conversion among Smear-Positive pulmonary tuberculosis patients in Morocco. ISRN Pulmonol. 2013;2013:1\u20135.","journal-title":"ISRN Pulmonol"},{"key":"11873_CR12","doi-asserted-by":"crossref","unstructured":"Gunda DW, Nkandala I, Kavishe GA, Kilonzo SB, Kabangila R, Mpondo BCT. Prevalence and risk factors of delayed sputum conversion among patients treated for smear positive pulmonary tuberculosis in northwestern rural Tanzania: A retrospective cohort study. J Trop Med. 2017;2017:5352906. doi:10.1155\/2017\/5352906","DOI":"10.1155\/2017\/5352906"},{"issue":"2","key":"11873_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1128\/AAC.4.2.94","volume":"4","author":"GL Hobby","year":"1973","unstructured":"Hobby GL, Holman AP, Iseman MD, Jones JM. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother. 1973;4(2):94\u2013104.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"11873_CR14","first-page":"0","volume":"2","author":"Obiora","year":"2017","unstructured":"Obiora, et al. Sputum conversion among new smear positive pulmonary tuberculosis patients attending tb\/dots clinics in Anambra state, Nigeria. Pulm Crit Care Med. 2017;2(3):0\u20133.","journal-title":"Pulm Crit Care Med"},{"issue":"3","key":"11873_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4046\/trd.2017.0096","volume":"81","author":"S Diktanas","year":"2018","unstructured":"Diktanas S, Vasiliauskiene E, Polubenko K, Danila E, Celedinaite I, Boreikaite E, et al. Factors associated with persistent sputum positivity at the end of the second month of tuberculosis treatment in Lithuania. Tuberc Respir Dis (Seoul). 2018;81(3):233\u201340.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"11873_CR16","unstructured":"Centers for Disease Control and Prevention (CDC). Reported tuberculosis in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2020."},{"issue":"9","key":"11873_CR17","first-page":"1","volume":"8","author":"FR Kayigamba","year":"2013","unstructured":"Kayigamba FR, Bakker MI, Mugisha V, Naeyer L, De, Gasana M, Cobelens F, et al. Adherence to tuberculosis Treatment, sputum smear conversion and mortality : A retrospective cohort study in 48. Rwandan Clin. 2013;8(9):1\u201310.","journal-title":"Rwandan Clin"},{"key":"11873_CR18","unstructured":"Harries AD, Hargreaves NJ, Kemp J, Jindani A, Enarson DA, Maher D, Salaniponi FM. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi. Int J Tuberc Lung Dis. 2001;5(6):556\u2013564."},{"key":"11873_CR19","doi-asserted-by":"crossref","unstructured":"Reis-Santos B, Gomes T, Horta BL, Maciel EL. Predictors of delayed sputum smear and culture conversion among a Portuguese population with pulmonary tuberculosis. PLoS ONE. 2012;7(8):e42591. doi:10.1371\/journal.pone.0042591","DOI":"10.1371\/journal.pone.0042591"},{"key":"11873_CR20","first-page":"19","volume":"Cdc","author":"M G\u00fcler","year":"2007","unstructured":"G\u00fcler M, Unsal E, Dursun B, Aydln O, Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Natl Cent Biotechnol Inform. 2007;Cdc:19.","journal-title":"Natl Cent Biotechnol Inform"},{"key":"11873_CR21","unstructured":"Masut O, Boisset S, Epaulard O, Carricajo A, Dumollard C, Godreuil S, et al. Determinants of time to sputum smear conversion during lung tuberculosis therapy: a prospective cohort study from France. BMC Infect Dis. 2019;19(1):726. doi:10.1186\/s12879-019-4366-4"},{"key":"11873_CR22","doi-asserted-by":"crossref","unstructured":"Musteikien\u0117 G, Miliauskas S, Zaveckien\u0117 J, \u017demaitis M, Vitkauskien\u0117 A. Factors associated with sputum culture conversion in patients with pulmonary tuberculosis. Medicina (Kaunas). 2018;54(6):97. doi:10.3390\/medicina54060097","DOI":"10.1016\/j.medici.2018.01.005"},{"key":"11873_CR23","doi-asserted-by":"crossref","unstructured":"Patra S, Lukhmana S, Satyanarayana S, Kannan AT, Sharma G, Sreenivas A, Enarson DA, Chadha SS. Profile and treatment outcomes of elderly patients with tuberculosis in Delhi, India: implications for their management. Trans R Soc Trop Med Hyg. 2013;107(12):763\u2013768. doi:10.1093\/trstmh\/trt092","DOI":"10.1093\/trstmh\/trt094"},{"key":"11873_CR24","doi-asserted-by":"crossref","unstructured":"Hayibor KM, Bandoh DA, Asante-Poku A, Kenu E. Predictors of adverse TB treatment outcome among TB\/HIV patients compared with non-HIV patients in the Greater Accra Regional Hospital from 2008 to 2016. Tuberc Res Treat. 2020;2020:5020987. doi:10.1155\/2020\/5020987","DOI":"10.1155\/2020\/1097581"},{"key":"11873_CR25","unstructured":"Pajankar S, Khandekar R, Al Amri MA, Al Lawati MR. Factors influencing sputum smear conversion at one and two months of tuberculosis treatment. Oman Med J. 2008;23(4):263\u2013268. doi:10.5001\/omj.2008.51"},{"key":"11873_CR26","doi-asserted-by":"crossref","unstructured":"Anandaraj R, Anurupa MS, Kavithai P, Rashmi BM, Ranjitha A, Raghavendra SK. Factors influencing delay in sputum smear conversion among new smear-positive pulmonary tuberculosis patients of Davangere tuberculosis unit. Int J Community Med Public Health. 2018;5(9):3986\u20133991. doi:10.18203\/2394-6040.ijcmph20183609","DOI":"10.18203\/2394-6040.ijcmph20183609"},{"key":"11873_CR27","doi-asserted-by":"crossref","unstructured":"Gebreweld FH, Kifle MM, Gebremicheal FE, Simel LL, Gezae MM, Ghebreyesus SS, Mengsteab YT. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. J Health Popul Nutr. 2018;37(1):9. doi:10.1186\/s41043-017-0080-y","DOI":"10.1186\/s41043-017-0132-y"},{"key":"11873_CR28","doi-asserted-by":"crossref","unstructured":"Van der Werf TS, Dade GK, van der Mark TW. Patient compliance with tuberculosis treatment in Ghana: factors influencing adherence to therapy in a rural service programme. Tubercle. 1990;71(4):247\u2013252. doi:10.1016\/0041-3879(90)90036-6","DOI":"10.1016\/0041-3879(90)90036-8"},{"key":"11873_CR29","first-page":"231","volume":"3","author":"B Widjanarko","year":"2009","unstructured":"Widjanarko B, Gompelman M, Dijkers M, van der Werf MJ. Factors that influence treatment adherence of tuberculosis patients living in Java, Indonesia. Patient Prefer Adherence. 2009;3:231\u20138.","journal-title":"Patient Prefer Adherence"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11873-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:46:53Z","timestamp":1761659213000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11873-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11873"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11873-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was based on the analysis of secondary data obtained from Chest Hospital Jericho, Ibadan, Oyo state. Consent to use the data was obtained from the hospitals\u2019 management. All information was collected anonymously and held confidentially. All methods were carried out according to relevant guidelines and regulati.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1429"}}